Drug profile · INN
ivosidenib
TIBSOVO
ivosidenib (TIBSOVO) is a isocitrate dehydrogenase [nadp] cytoplasmic inhibitor. Associated with Servier Laboratories (Aust.) Pty.. Route of administration: oral. Current US regulatory status: approved.
Drug details — ivosidenib
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- ORAL
- Patents
- 9
- Programs
- 12
- Data quality
- 0.89
Quick answer
ivosidenib (TIBSOVO) is a isocitrate dehydrogenase [nadp] cytoplasmic inhibitor. Associated with Servier Laboratories (Aust.) Pty.. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
Primary target: Isocitrate dehydrogenase [NADP] cytoplasmic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 10980788
Therapy for treating malignancies
granted -
US 10799490
Pharmaceutical compositions of therapeutically active compounds
granted -
US 10717764
Therapeutically active compounds and their methods of use
granted -
US 10653710
Combination therapy for treating malignancies
granted -
US 10610125
Methods and compositions for cell-proliferation-related disorders
granted -
US 10449184
Pharmaceutical compositions of therapeutically active compounds
granted -
US 9968595
Pharmaceutical compositions of therapeutically active compounds
granted -
US 9850277
Therapeutically active compositions and their methods of use
granted -
US 9474779
Therapeutically active compositions and their methods of use
granted
Frequently asked questions
What is ivosidenib?
ivosidenib (TIBSOVO) is a isocitrate dehydrogenase [nadp] cytoplasmic inhibitor. Associated with Servier Laboratories (Aust.) Pty.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ivosidenib?
TIBSOVO is a marketed brand name for ivosidenib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ivosidenib?
ivosidenib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.